A fairly underwhelming response from the market this morning to this announcement. I guess the fact that clinical trials are not due to start for another 18-24 months (1st half of 2023) is a major factor. It seems like there'll be a fairly slow flow of news from PYC over the next 12-18 months or so, unless something comes out from left field. That's not going to help the share price appreciation much in the medium term imho. There could be some good buying opportunities in the months ahead.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
-0.055(4.23%) |
Mkt cap ! $726.1M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.24 | $173.1K | 139.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 33352 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 7691 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |